Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $124.00, but opened at $118.50. Pro Medicus shares last traded at $118.50, with a volume of 40 shares changing hands.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $155.00.
Get Our Latest Research Report on Pro Medicus
Pro Medicus Stock Performance
About Pro Medicus
Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Featured Articles
- Five stocks we like better than Pro Medicus
- Lululemon’s Earnings Beat Hid a Bigger Problem for Its Turnaround Story
- MarketBeat Week in Review – 08/31 – 09/04
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
